Lord Neuberger in Actavis v Eli Lilly [2017] RPC 21, para. 57.

Slides:



Advertisements
Similar presentations
CIER-lezing Ex parte maatregelen
Advertisements

Incorporation by Reference
Cluster Meeting, 9 th February 2006 Legal issues in Open Source Software (OSS) Dr Zoe Kardasiadou (CIEEL)
Anatomy of a Patent Application Presented by: Jeong Oh Director, Office of Technology Transfer & Industrial Development Syracuse University April 30, 2009.
Patent & Trade Secrets Law Bill Richardson and Ariel Neuer University of Toronto February 28, 2012.
Patent Law and Policy University of Oregon Law School Fall 2009 Elizabeth Tedesco Milesnick Patent Law and Policy, Fall 2009 Class 11, Slide 1.
September 14, U.S.C. 103(c) as Amended by the Cooperative Research and Technology Enhancement (CREATE) Act (Public Law ) Enacted December.
Invention Spotting – Identifying Patentable Inventions Martin Vinsome June 2012.
Claim Interpretation By: Michael A. Leonard II and Jared T. Olson.
Patent Protection of Technical Equivalents in Germany Prof. Dr. Christian Osterrieth Copenhagen August 2008.
Patent Overview by Jeff Woller. Why have Patents? Patents make some people rich – but, does that seem like something the government should protect? Do.
Patents 101 April 1, 2002 And now, for something new, useful and not obvious.
Gap Fillers Contracts – Prof Merges What is a gap filler? Implied terms – terms that courts will “read into” a K But not terms the parties.
Secondary Use Patents: An international and Canadian perspective E. Richard Gold James McGill Professor, McGill Faculty of Law Secondary Use Pharmaceutical.
John B. Pegram Fish & Richardson P.C. U.S. Federal Court Rule Changes 1 © AIPLA 2015.
Utility Requirement in Japan Makoto Ono, Ph.D. Anderson, Mori & Tomotsune Website:
AIPPI seminarParis, 7 November 2013 Karsten Koeniger, Harmsen Utescher 1 Patents: Infringement under the doctrine of equivalence - Germany - Karsten Koeniger,
Patentability of Software and Business Methods A UK and EPO Update Richard Davis Hogarth Chambers May 13, 2011
Notice of Proposed Rule Making Affecting Claims That Recite Alternatives 1 Robert Clarke, Director Office of Patent Legal Administration (571)
European Patent Applicants Filing in China Common Mistakes Zheng Li Zhongzi Law Office September, 2014.
Patent Claim Construction: What does the claim mean? Donald M. Cameron 2015.
Professor Peng  Patent Act (2008) ◦ Promulgated in 1984 ◦ Amended in 1992, 2000, and 2008.
PatentEng-Berkeley-Lavian Week 6: Validity and Infringement 1 Patent Engineering IEOR 190G CET: Center for Entrepreneurship &Technology Week 6 Dr. Tal.
July 18, U.S.C. 103(c) as Amended by the Cooperative Research and Technology Enhancement (CREATE) Act (Public Law ) Enacted December 10,
Heli PihlajamaaLondon, Director Patent Law (5.2.1) Clarity - Article 84 EPC.
1 Written Description Analysis and Capon v. Eshhar Jeffrey Siew Supervisory Patent Examiner AU 1645 USPTO (571)
Support for the Modernisation of the Mongolian Standardisation system – EuropeAid/134305/C/SER/MN Training on standardisation Support to the Modernisation.
1 Patent Claim Interpretation under Art. 69 EPC – Should prosecution history be used to interpret the patent? presented at Fordham 19th Annual Conference.
PATENTS, INTEGRATED CIRCUITS, AND INDUSTRIAL DESIGNS Presented By: Navdeep World Trade Organization.
Class 24: Finish Remedies, then Subject Matter Patent Law Spring 2007 Professor Petherbridge.
Abstract  An abstract is a concise summary of a larger project (a thesis, research report, performance, service project, etc.) that concisely describes.
Charles University – Law Faculty October 2012 © Peter Kolker 2012 Class III
UK claim interpretation: “purposive construction” Peter Hale.
Conditions and warranties. Introduction The law relating to sale and purchase of goods, prior to 1930 were dealt by the Indian Contract Act, In.
TRADE SECRETS workshop I © 2009 Prof. Charles Gielen EU-China Workshop on the Protection of Trade Secrets Shanghai June 2009.
TOPICS – THIS SESSION Domestic Enquiry Principles of Natural Justice
Recognizing the Client
INTELECTUAL PROPERTY RIGHTS
Tech Mahindra Limited v Commissioner of Taxation
Brussels Privacy Symposium on Identifiability
Intellectual Property Owner’s Manual
International Conference on Judicial Protection of IPR
Recent IP Case in Japan Construction of Functional Claim
Parts of standard unmodified opinion audit report
Preparing a Patent Application
Glossary of Terms Used in Science Papers AS
SCIENTIFIC & TECHNICAL WRITING Patents
Patents VI Infringement & the Doctrine of Equivalents
THE QUESTIONS—SKILLS ANALYSE EVALUATE INFER UNDERSTAND SUMMARISE
Patentability of AI related inventions
The Spanish doctrine of equivalents after alimta®
OTHER INVALIDITY CHALLENGES
Global Innovation Management Workout on Writing a Patent
Audit Reports Chapter 3.
TORTS RELATING TO INCORPOREAL PROPERTIES
Law 677 | Patent Law | Spring 2003
INTRODUCTION INTO PRIVATE INTERNATIONAL LAW OF THE EUROPEAN UNION
Sub-Regional Meeting for ASEAN Countries on the Marrakesh Treaty and the Production and Exchange of Accessible Books by the World Intellectual Property.
Doctrine of Equivalents
Apple v. Samsung: Product Design
Preparing a Case Brief.
Preparing a Patent Application
Upcoming changes in the European Patent Office practice on allowing claim amendments in pending patent applications (Article 123(2) EPC) Christof Keussen.
Subject Matter Eligibility
A tutorial and update on patentable subject matter
The reference for a preliminary ruling concerns the interpretation of Articles 2, 3 and 8 of Council Framework Decision 2001/220/JHA of 15 March 2001.
OFFER AND ACCEPTANCE Offer or Proposal Essential Elements of a Valid Contract discussed in detail Section 2(a) defines an offer as, “ a proposal made by.
Patent Claims: Scope of Protection, Equivalence
Claim construction and associated problems in France
Presentation transcript:

Lord Neuberger in Actavis v Eli Lilly [2017] RPC 21, para. 57. “…The notion of a product or process which infringes despite an immaterial variation from the invention as claimed is by no means new to domestic patent law. Thus, in Walton v Potter & Horsfall (1843) 1 Web PC 585, Tindal C.J. told the jury that they had to decide whether the defendant’s product was “perfectly distinct” from the patented product, or whether it varied “only in certain circumstances, which are not material to the principle and substance of the invention”.

Section 5(5) of the Patents, Designs and Trade Marks Act 1883 “A specification, whether provisional or complete, must commence with the title, and in the case of a complete specification must end with a distinct statement of the invention claimed. ”

Lord Herschel in Nobel's Explosives Co v Anderson (1895) “Where a Patentee claims … the combination of two chemical substances named and specified, he cannot extend, or claim to extend, the protection of his patent to a combination of other substances than those which he has so specified, because such other combination may be found to produce a substance having substantially the same qualities and capable of employment in the same way.”

Lord Russell in EMI v Lissen (1938) “The function of the claims is to define clearly and with precision the monopoly claimed, so that others may know the exact boundaries of the area within which they will be trespassers. Their primary object is to limit, and not to extend, the monopoly. What is not claimed is disclaimed. The claims must undoubtedly be read as part of the entire document, and not as a separate document. Nevertheless, the forbidden field must be found in the language of the claims, and not elsewhere.” 

Claims EUROPEAN PATENT CONVENTION Article 84   The claims shall define the matter for which protection is sought. They shall be clear and concise and be supported by the description. 

Article 69 Extent of protection EUROPEAN PATENT CONVENTION Article 69   The extent of the protection conferred by a European patent or a European patent application shall be determined by the claims. Nevertheless, the description and drawings shall be used to interpret the claims. 

Claims EUROPEAN PATENT CONVENTION Article 84   The claims shall define the matter for which protection is sought. They shall be clear and concise and be supported by the description. 

EUROPEAN PATENT CONVENTION Protocol on the Interpretation of article 69 Article 1 General principles Article 69 should not be interpreted as meaning that the extent of the protection conferred by a European patent is to be understood as that defined by the strict, literal meaning of the wording used in the claims, the description and drawings being employed only for the purpose of resolving an ambiguity found in the claims. Nor should it be taken to mean that the claims serve only as a guideline and that the actual protection conferred may extend to what, from a consideration of the description and drawings by a person skilled in the art, the patent proprietor has contemplated. On the contrary, it is to be interpreted as defining a position between these extremes which combines a fair protection for the patent proprietor with a reasonable degree of legal certainty for third parties. Article 2 Equivalents For the purpose of determining the extent of protection conferred by a European patent, due account shall be taken of any element which is equivalent to an element specified in the claims.

Lord Neuberger in Actavis v Eli Lilly [2017] RPC 21, para. 56. As Sir Hugh Laddie wrote … “[t]he Protocol is not concerned with the rules of construction of claims” but with “determining the scope of protection”.

Lord Neuberger in Actavis v Eli Lilly [2017] RPC 21, para. 53. In the “Epilady” patent, where it could not seriously have been suggested that, as a matter of language, a slotted rubber rod falls within the expression “helical metal spring”, even if one was construing those words in the context of the claim in the patent in suit. But, if one departs from ordinary language, it is necessary to have some guidance or to draw some lines, as Lord Hoffmann implied in Kirin-Amgen [2005] R.P.C. 9, at [37]. That is why he promulgated his three questions in Improver [1990] F.S.R. 181, at p. 189. By means of an extended version of the ordinary concept of “construction” or “interpretation”, Hoffmann J. explained how our domestic law, as laid down in Catnic [1982] R.P.C.183, implements art.2 of the Protocol and thus, as I see it, how it gives effect to the doctrine of equivalents.

The old rules on purposive construction of the claims Improver Corp v Remington Consumer Products Ltd [1990] F.S.R. 181 The old rules on purposive construction of the claims “If the issue was whether a feature embodied in an alleged infringement which fell outside the primary, literal or acontextual meaning of a descriptive word or phrase in the claim (‘a variant’) was nevertheless within its language as properly interpreted, the court should ask itself the following three questions: (1) Does the variant have a material effect upon the way the invention works? If yes, the variant is outside the claim. If no - (2) Would this (ie that the variant had no material effect) have been obvious at the date of publication of the patent to a reader skilled in the art? If no, the variant is outside the claim. If yes - (3) Would the reader skilled in the art nevertheless have understood from the language of the claim that the patentee intended that strict compliance with the primary meaning was an essential requirement of the invention? If yes, the variant is outside the claim.

Lord Neuberger in Actavis v Eli Lilly [2017] RPC 21, para. 66. The new test for protection of equivalents: “(i) Notwithstanding that it is not within the literal meaning of the relevant claim(s) of the patent, does the variant achieve substantially the same result in substantially the same way as the invention, i.e. the inventive concept revealed by the patent? (ii) Would it be obvious to the person skilled in the art, reading the patent at the priority date, but knowing that the variant achieves substantially the same result as the invention, that it does so in substantially the same way as the invention? (iii) Would such a reader of the patent have concluded that the patentee nonetheless intended that strict compliance with the literal meaning of the relevant claim(s) of the patent was an essential requirement of the invention?”

Arnold J in Actavis v Eli Lilly [2015] RPC 21, para. 104.  Experience shows that patentees resort to arguments about equivalents in three main classes of case. The first is where, with the benefit of hindsight, it can be seen that the patent was unfortunately drafted, whether because of poor instructions from the inventor or poor drafting by his patent attorney or a combination of these things. Improver  might perhaps be regarded as an example of this. The second class is where technology has moved on since the priority or filing date of the patent. Kirin-Amgen  might perhaps be regarded as an example of this. The third class is where the patentee now regrets a decision taken during the course of prosecution of the patent application, whether by himself or by the examiner, and is trying to avoid the consequences of that decision.

Kirin-Amgen, paragraph 47. The Protocol says that the object is to combine a fair protection for the patentee with a reasonable degree of certainty for third parties. How is this to be achieved? The claims must be construed in a way which attempts, so far as is possible in an imperfect world, not to disappoint the reasonable expectations of either side. What principle of interpretation would give fair protection to the patentee? Surely, a principle which would give him the full extent of the monopoly which the person skilled in the art would think he was intending to claim. And what principle would provide a reasonable degree of protection for third parties? Surely again, a principle which would not give the patentee more than the full extent of the monopoly which the person skilled in the art would think that he was intending to claim.